Theranostics Centre in Delhi NCR offers Lu-177 PSMA therapy in India, an advanced treatment for metastatic prostate cancer in India. This therapy uses a molecule that targets PSMA, a protein highly expressed on prostate cancer cells, delivering precise radiation directly to tumors while sparing healthy tissue. Like a guided missile, it seeks out cancer cells, offering effective, targeted therapy for prostate cancer patients. For those seeking Lu-177 PSMA therapy for prostate cancer in Delhi NCR or PSMA therapy in India, Theranostics Centre provides cutting-edge care and personalized treatment plans.
Resource: https://theranos.care/targeted....-lu-177-lutetium-psm
